Colleen Tupper - 15 Mar 2023 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role: EVP & Chief Financial Officer
Signature: /s/ Colleen Tupper
Issuer symbol: COLL
Transactions as of: 15 Mar 2023
Transactions value $: -$752,165
Form type: 4
Filing time: 17 Mar 2023, 16:11:14 UTC
Previous filing: 14 Feb 2023
Next filing: 14 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COLL	Common Stock	Sale	-$752K	-31.6K	-23.08%	$23.77	105K	15 Mar 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.
F2	The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.47 to $24.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.

The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.47 to $24.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).